rphra
live
S&P 5007,359.9-0.08%
NASDAQ29,220.06-0.43%
DOW51,848.9+0.35%
VIX18.63-4.41%
US10Y4.40-1.98%
EUR/USD1.1361-1.26%
GOLD4,014.5-6.65%
WTI69.62-7.44%
BTC60,676-5.84%
S&P 5007,359.9-0.08%
NASDAQ29,220.06-0.43%
DOW51,848.9+0.35%
VIX18.63-4.41%
US10Y4.40-1.98%
EUR/USD1.1361-1.26%
GOLD4,014.5-6.65%
WTI69.62-7.44%
BTC60,676-5.84%

TPIA

Mycotopia Therapies, Inc.
HealthcareMedical - Care FacilitiesUSUSDPeers →via fmp_bulk
$0.02
LiveFeb 14, 2025
AI Brief
Market cap
$113.83K
52w range
0.01 – 0.18
P / E
EPS
Volume
73.92K
Revenue · FY

Explain this page

Arphra AI
Business description
· company · SEC profile

Mycotopia Therapies, Inc.

Mycotopia Therapies, Inc. specializes in the application of psychedelic compounds to address a range of mental health conditions. The company offers therapeutic interventions for ailments such as post-traumatic stress disorder (PTSD), severe anxiety, depression, and serotonin syndrome, in addition to providing support for palliative care. Headquartered in Aventura, Florida, Mycotopia Therapies, Inc. operates as a subsidiary of EHAVE, Inc.

Founded
IPO
Mar 31, 2006
Employees
1
HQ
Aventura, FL
CEO
Benjamin Kaplan
CFO
Exchange
OTC
Fiscal year
Identifiers
· company_identifiers
CIK0001763329
CUSIP62846W107
ISINUS62846W1071
FIGI
LEI